Using comorbidity indexes to predict costs for head and neck cancer

Medicine and Dentistry

• Health Care Cost 100%
• Head and Neck Cancer 100%
• Comorbidity 100%
• Medicare 30%
• Charlson Comorbidity Index 20%
• Observational Study 10%
• Linear Regression Analysis 10%
• Elderly Patient 10%
• Surveillance, Epidemiology, and End Results 10%
• Prognostication 10%
• Treatment Modality 10%

Keyphrases

• Head-and-neck Cancer 100%
• Comorbidity Index 100%
• University of Washington 50%
• Charlson Comorbidity Index 20%
• Linear Regression 10%
• Treatment Modalities 10%
• Elderly Patients 10%
• Retrospective Observational Study 10%
• Treatment Costs 10%
• Patient Outcomes 10%
• Medicare 10%
• Cost Controlling 10%
• Medicaid Patients 10%
• Medicare Reimbursement 10%
• Cancer-specific 10%
• Linked Databases 10%
• Surveillance Epidemiology 10%

Nursing and Health Professions

• Head and Neck Cancer 100%
• Comorbidity 100%
• Medicare 30%
• Charlson Comorbidity Index 20%
• Linear Regression Analysis 10%
• Treatment Outcome 10%
• Elderly Patient 10%
• Prognostication 10%
• Epidemiology 10%